Both HealthyLivestock and AVANT directly address reducing antimicrobial use in farm animals through improved health management and alternative interventions.
FEDERATION OF VETERINARIANS OF EUROPE
Pan-European veterinary professional federation specializing in antimicrobial stewardship, biosecurity, and livestock health policy across EU member states.
Their core work
The Federation of Veterinarians of Europe (FVE) is the pan-European professional body representing national veterinary associations across EU member states. In H2020 research, they play a policy and dissemination role — bringing veterinary professional expertise, European-wide networks, and regulatory context to research consortia that would otherwise lack a bridge to practitioners and policymakers. Their participation in AMR-focused projects reflects the veterinary profession's frontline role in antibiotic stewardship: veterinarians prescribe antimicrobials, advise on biosecurity, and are the primary implementers of alternatives. FVE translates research outputs into professional guidance that reaches tens of thousands of practicing veterinarians across Europe.
What they specialise in
HealthyLivestock (2018–2023) focused on biosecurity, resilience, and animal welfare as systemic levers for reducing antibiotic dependency at farm level.
AVANT (2020–2025) covers bacteriophages, immunostimulants, gut stabilizers, and specific feed strategies as replacements for antibiotics in pig production.
As a pan-European NGO with no coordinator roles, FVE consistently contributes professional network reach and policy translation rather than primary research execution.
How they've shifted over time
FVE's H2020 engagement began with the broad systemic framing of AMR — biosecurity, resilience, and animal welfare as interconnected factors in antibiotic reduction (HealthyLivestock, 2018). By 2020, the focus narrowed considerably to specific technical alternatives: bacteriophages, immunostimulants, gut stabilizers, and targeted feed strategies tested in pig farm trials (AVANT). This reflects a wider sector shift from awareness and framework-setting toward concrete, deployable interventions with measurable impact on antimicrobial consumption.
FVE is moving from policy advocacy toward active participation in field-tested alternative therapies, suggesting future collaboration potential in applied AMR reduction programs targeting specific livestock species.
How they like to work
FVE has participated exclusively as a consortium partner across both projects, never as coordinator — consistent with their role as a professional federation rather than a research-executing entity. They engage in large consortia (averaging roughly 20 partners per project across 13 countries), which suits their strength in broad dissemination and professional network activation. They are best understood as a legitimacy and outreach partner: their value to a consortium is access to practicing veterinarians and national associations, not laboratory capacity.
FVE has built connections with 40 unique consortium partners across 13 countries through just two projects — a high partner density suggesting large, multi-national consortia typical of Horizon 2020 RIA and IA instruments. Their network skews toward European livestock research institutions, veterinary schools, and agricultural bodies.
What sets them apart
FVE is one of very few organizations that can simultaneously reach veterinary practitioners in 40+ European countries through established professional channels — something no university or research institute can replicate. For any consortium working on antimicrobial resistance, animal health policy, or veterinary practice change, FVE provides direct access to the professionals who will actually implement research outcomes. Their Brussels location and EU-level mandate also give them a natural role in projects needing regulatory or policy dissemination to EU institutions.
Highlights from their portfolio
- HealthyLivestockThe larger of their two projects (€307,025), it tackled AMR from a systems perspective — combining biosecurity, welfare, and health management — reflecting FVE's broadest policy remit.
- AVANTRepresents a concrete pivot to testable alternatives (bacteriophages, immunostimulants) in pig production, signaling FVE's engagement with applied science beyond policy advocacy.